Tag: Stedim
Sartorius Stedim Biotech: the decline continues
By Jean-Baptiste André Published on 04/19/2024 at 3:28 p.m. Photo credit © Sartorius Stedim Biotech (Boursier.com) —…
Sartorius Stedim Biotech announces a dividend of 0.69 euros per share
(AOF) – Sartorius Stedim Biotech announces that during its meeting today, the board of directors decided to propose to the combined annual general meeting of shareholders, scheduled for March 26,…
Sartorius Stedim: private placement of 5.15 million shares – 02/07/2024 at 07:43
(CercleFinance.com) – Sartorius Stedim Biotech announces having successfully placed 5,150,215 shares with institutional investors, as part of an international private placement through the construction of an accelerated order book. The…
Sartorius Stedim Biotech launches an offering of new shares for 1.2 billion euros
(AOF) – Sartorius Stedim Biotech announces the launch of an offering of new shares for an amount of approximately 1.2 billion euros, with elimination of shareholders’ preferential subscription rights through…
Sartorius Stedim forecasts a more positive trend in 2024 – 01/26/2024 at 12:00
(AFP / PHILIPPE LOPEZ) The supplier of materials for the biopharmaceutical sector Sartorius Stedim Biotech (SSB) saw its profitability weighed down in 2023 by weak post-Covid demand, but expects activity…
Sartorius Stedim Biotech: the right price?
By Hector Chaunu Published on 06/12/2023 at 10:35 a.m. Sartorius Stedim Biotech regains 0.9% this Wednesday, to 198.50 euros, while JP Morgan remains ‘overweight’…
Changes in recommendations in Paris: Virbac, Alstom, Sartorius Stedim – 10/24/2023 at 10:10
This analysis was prepared by Reuters and broadcast by BOURSORAMA on 10/24/2023 at 10:10:00. Acting exclusively as a distribution channel, BOURSORAMA did not participate in any way in its development…
Sartorius Stedim Biotech recovers despite degraded results
(AOF) – Sartorius Stedim Biotech (+6.38% to 198.40 euros) is recovering after publication of its nine-month results. The pharmaceutical industry supplier was harshly sanctioned last Friday after issuing a new…
Sartorius Stedim Biotech: “warning” on turnover and EBITDA margin
By Arnaud Bivès Published on 10/13/2023 at 8:26 a.m. Photo credit © Sartorius Stedim Biotech (Boursier.com) — According…
Sartorius Stedim Biotech: plunges after the new warning
By Jean-Baptiste André Published on 10/13/2023 at 9:13 a.m. Photo credit © Sartorius Stedim Biotech (Boursier.com) — Sartorius…
Sartorius Stedim Biotech confident about its prospects – 10/13/2023 at 08:46
(AOF) – According to preliminary figures, Sartorius Stedim Biotech recorded a consolidated turnover of around 2.069 billion euros during the first nine months of 2023, a decline of almost 19%…
Sartorius Stedim: downward revision of 2023 objectives – 10/13/2023 at 09:10
Sartorius equipment. (photo credit: Sartorius AG / ) (CercleFinance.com) – On the occasion of a preliminary publication, Sartorius Stedim Biotech reduced its forecasts for 2023, now expecting a drop in…